Taiwan FDA registration dad00d14e034b26954acfcd1eea9725f
Vtron point-of-care blood glucose testing system
TW: 威創定點照護血糖測試系統
Taiwan·Risk Class 2·Taibo Technology Co., Ltd. five-stock factory·Registered Jan 03, 2024 – Jan 03, 2029ActiveRegistration details
- Analysis ID
- dad00d14e034b26954acfcd1eea9725f
Company information
- Manufacturer
- Taibo Technology Co., Ltd. five-stock factory
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- TAIDOC TECHNOLOGY CORPORATION
Product details
- Intended Use
- It is suitable for professionals to quantify venous blood or fingertip microvascular whole blood.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1345 Glucose Test System
- Import Information
- 國產;; QMS/QSD
Dates and status
- Registration Date
- Jan 03, 2024
- Expiry Date
- Jan 03, 2029
About this record
Access comprehensive regulatory information for Vtron point-of-care blood glucose testing system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number dad00d14e034b26954acfcd1eea9725f and manufactured by Taibo Technology Co., Ltd. five-stock factory. The authorized representative in Taiwan is TAIDOC TECHNOLOGY CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices